Explore the words cloud of the OMVCRC project. It provides you a very rough idea of what is the project "OMVCRC" about.
The following table provides information about the project.
Coordinator |
UNIVERSITA DEGLI STUDI DI TRENTO
Organization address contact info |
Coordinator Country | Italy [IT] |
Total cost | 150˙000 € |
EC max contribution | 150˙000 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2017-PoC |
Funding Scheme | ERC-POC |
Starting year | 2018 |
Duration (year-month-day) | from 2018-01-01 to 2019-06-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSITA DEGLI STUDI DI TRENTO | IT (TRENTO) | coordinator | 93˙750.00 |
2 | FONDAZIONE TOSCANA LIFE SCIENCES | IT (SIENA) | participant | 56˙250.00 |
This proposal originates from recent results obtained in the course of the Advanced ERC Project “OMVac”, the scope of which is to exploit the unique adjuvanticity properties of bacterial Outer Membrane Vesicles (OMVs) for developing innovative vaccines against infectious diseases and cancer. In particular, Synthetic Biology was applied to engineer OMVs with FAT1, a tumour associated antigen expressed in most primary and metastatic colorectal cancers (CRC). Using cancer models in immunocompetent mice, immunization with FAT1-decorated OMVs inhibited subcutaneous growth of FAT1-positive CT26 cancer cells and protection correlated with an increase in tumour infiltration of CD4/CD8 T cells and concomitant decrease of Treg and MDSCs. These promising results prompted the submission of the present proposal which has as main objectives: 1) the demonstration that FAT1-OMV immunization can synergise with the protective activity of checkpoint inhibitors, and 2) the development of a scalable FAT1-OMV production and purification process which could allow testing FAT1-OMV/checkpoint inhibitor combination in the clinical setting.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
Alberto Grandi, Laura Fantappiè, Carmela Irene, Silvia Valensin, Michele Tomasi, Simone Stupia, Riccardo Corbellari, Elena Caproni, Ilaria Zanella, Samine J. Isaac, Luisa Ganfini, Luca Frattini, Enrico König, Assunta Gagliardi, Simona Tavarini, Chiara Sammicheli, Matteo Parri, Guido Grandi Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models published pages: , ISSN: 2234-943X, DOI: 10.3389/fonc.2018.00481 |
Frontiers in Oncology 8 | 2020-01-21 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OMVCRC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OMVCRC" are provided by the European Opendata Portal: CORDIS opendata.